Learn more about Peter Attia’s digital program
Silencing the alarm over a recent paper on dietary protein and atherosclerosis
A recent report that high protein intake contributes to atherosclerosis has limited relevance to anyone but transgenic mice
Research Worth Sharing, March 2024 Edition
Organ-specific aging, a blood-based test for brain tumors, avoiding bananas in smoothies, stair-climbing tests for frailty, and omega-3 intake and CVD
Does time-restricted eating increase the risk of cardiovascular death?
Why I don’t put any stock in a recent “study”
Removing race as a risk factor for cardiovascular disease?
The AHA has announced a new “race-free” assessment tool, but eliminating this variable carries the potential to increase – rather than decrease – racial disparities in healthcare
Saunas: the facts, the myths, and the how-to
Sauna use appears to be genuinely beneficial, but not all claims stand up to scrutiny
Where a study on metformin and cardiovascular disease fell short – and what it can teach us
An investigation on metformin, diabetes, lipid biology, and cardiovascular disease offered little insight on any of these topics, but it illustrates common problems in scientific research
Is low-to-moderate alcohol consumption beneficial for longevity?
There is a common belief that low-to-moderate consumption of alcohol has unique health benefits. What does the evidence show?
Reassessing the relationship between alcohol intake and cardiovascular disease risk
Mendelian randomization offers clearer insights than epidemiology or randomized trials to date
Continuous glucose monitoring to improve health in non-diabetics
Individualizing blood glucose control and its benefits
Do GLP-1 receptor agonists improve cardiovascular health independently of weight loss?
A new trial has reported that the GLP-1 receptor agonist semaglutide reduces risk of cardiovascular events in patients with obesity – but that’s not the question we ought to be asking.